HILLARY HUGHES

1001 MARINA DRIVE, NO. 204E BOSTON, MA

02171
MOBILE: (617) 276-5450 EMAIL:
HAH02171@MSN.COM

SUMMARY
Solid Sales Professional consistently ranked in the Top 10%. Sales expertise in biotech and device
companies selling injectables and devices. Self-directed leader who excels at launching novel products
with excellent business acumen in penetrating key markets. Keen understanding of reimbursement in
institutions and clinics working the total hospital and practice to advance sales.

E X P E R I E NC E
PDI ( H os p ira and Pf ize r ) 2008
– 2010
Specialty Sales Representative

Sell LifeShield Clave Connector oncology device to medical oncologists and pharmacy departments. This
product prevents chemotherapy leakage. Market LifeShield TKO Anti-Reflux Device to prevent blood clots
in PICC lines. Target critical care and infusion therapy departments at Dana Farber Cancer Institute,
Dartmouth-Hitchcock Cancer Center and key New England hospitals. Also sell Protonix (Pantoprazole) for
gastro-esophageal reflux disease to gastroenterologists.
• No. 1 in the nation, Total Sales Performance, 121% Sales-to-Quota - 2009

NOVARTIS
Senior Oncology Hospital Sales Specialist (2006- 2008)
2004 - 2008
Oncology Sales Specialist (2004- 2006)

Promoted injectable and oral oncology products (Femara for breast cancer, Zometa I.V. for metastatic
bone cancer, and Sandostatin IM for GI cancer and acromegaly). Key call points included medical and
surgical oncologists, pathology, pharmacy and infusion therapy departments in hospitals. Major accounts
in Boston were Mass General Hospital, Dana Farber Cancer Institute, Brigham and Women's Hospital, Beth
Israel Deaconess Medical Center, Tufts Medical Center and Boston Medical Center.
• Received Most Valuable Player Award for sales team leadership contribution - 2004
• Received Peer-To-Peer Recognition Award for developing KOL's - 2004, 2005, 2006, 2007, 2008

• Promoted to elite status of Senior Oncology Hospital Sales Specialist within two years

HOFFMAN LA ROCHE
Senior Hospital Sales Specialist 2002 -
2004
Marketed Hepatitis C injectable, Pegasys, to GI physicians at Mass General Hospital, Beth Israel Deaconess
Medical Center, Brigham and Women's Hospital, Boston Medical Center and Tufts Medical Center. Also
sold HIV injectable/oral products (Saquinavir PO, Fuzeon IM, and Valycte PO). Hospital call points included
HIV clinics, infectious disease physicians and pharmacy. Spearheaded development of the National HIV
Field Nursing Support Program for patients, resulting in Roche HIV brand awareness and acceptance within
provider community, increasing overall sales attainment. Leveraged relationships with specialty and mail
order pharmacies to deliver outstanding customer service and pull-through assistance for specialty
biologics.
• No. 2 in the nation for HIV sales (Fuzeon and Saquinavir), 112 % Sales-to-Quota - 2003
• Received Special Sales Achievement Award for sales, product knowledge, customer focus, teamwork -
2003

A L Z A /O R T H O B I O T E C H
Senior Oncology Sales Specialist 2000 -
2002

Sold injectable oncology products (Doxil IV for ovarian cancer, Ethyol IV for head and neck cancer, Procrit
IV for anemia) targeting hematologists, medical oncologists, radiation oncologists, and head and neck
cancer specialists. Territory included community and hospital-based accounts in the Boston Metro area
and Rhode Island. Also sold Durgesic, transdermal pain product, focusing on cancer pain specialists, pain
management centers and palliative care specialists.
• Increased territory sales of Doxil IV and Ethyol IV from 81% to 123% within first seven months - 2000
• Selected to act as Sales Trainer for Eastern Region sales team for four oncology products - 2000

GLAXO WELLCOME
Senior Executive Oncology Sales Specialist (1997-2000)
1990 - 2000
Senior Oncology/HIV Sales Representative (1995-1997)
Medical Center Sales Representative (1990-1995)
Demonstrated sales success with oncology pharmaceutical agents - Zofran PO/IV and Navelbine IV. Key
core list included medical oncology, hematology oncologists and hospitals. Also promoted HIV
pharmaceutical agents (Epivir, Combivir, Retrovir PO/IV, Mepron, Valtrex, Zovirax IV) targeting HIV
Specialists, infectious disease physicians, and government-based programs. Elected to community
advisory boards, such as Rhode Island HIV Prevention Committee and Boston’s Community Research
Initiative HIV Advisory Board. Gained additional sales leadership experience by conducting oncology sales
training workshops for 100 new hires.
• No. 1 of 95 representatives, 116% Sales-to-Quota for Navelbine and Zofran, Eastern Region - 1999
• Received District Leadership Award for leadership and sales in Northeast District - 1997, 1998, 1999
• Received Commitment to Excellence Award - Highest Sales with Highest Market Share -1999
• Selected to participate on Oncology Advisory Panel -1998
• No. 2 in nation for Oncology Sales Division- President's Club Award for 150% Sales-to-Quota - 1998
• Achieved Oncology Peak Performer Award for “outstanding performance throughout the entire year”
-1998
• National Super Achiever Award - 100% of goal for 6 Products in Oncology and HIV Franchise -1996
• Received Onc/HIV Division Scorecard Award - Outstanding Performance and Support of the Mission
-1995

EDUCATION
UNIVERSITY OF MASSACHUSETTS
Bachelor of Science – Honors Biochemistry and General Chemistry
1 00 % Se l f-fi nanc e d. Grade poi nt ave rage 3 .7
Phi Be ta K appa and Phi K appa Phi Honors Di sti nc ti on

ONCOLOGY CLINICAL PRECEPTORSHIPS

Dartmouth Hitchcock Cancer Center, Johns Hopkins Medical Center, MD Anderson Cancer Center, Dana
Farber Cancer Institute, Arizona Health Science Center

HIV C L I N I C A L P R E C E P T O R S H I P S
San Francisco General Hospital, Jefferson Medical Center, Mass General Hospital

NEUROLOGY CLINICAL PRECEPTORSHIP

Columbia Presbyterian Medical Center

REFERENCES AVAILABLE UPON REQUEST